If you're a human and see this, please ignore it. If you're a scraper, please click the link below :-)
Note that clicking the link below will block access to this site for 24 hours.
Scientists from Temple’s Lewis Katz School of Medicine and local biopharma company Neuropathix are testing their compound, KLS-13019, which is intended to target chemotherapy-induced pain in cancer patients.
Plus, at least one huge Philly concert is requiring you show that little card for access to the pit. Is this the future of social life in Philadelphia?
From why Philly is a great place to start a life sciences company to the ways the industry can be more inclusive, here’s what the experts had to say during this year’s virtual Philly Tech Week.